U.S. Preventive Services Task Force, Rockville, Maryland, USA.
Ann Intern Med. 2012 Dec 18;157(12):900-4. doi: 10.7326/0003-4819-157-11-201212040-00539.
Reaffirmation of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for ovarian cancer.
A 2008 review of the literature commissioned by the USPSTF revealed no new evidence about the benefits of screening for ovarian cancer but provided some new data about observed harms of screening. A bridge search to 2011 focused on evidence from randomized, controlled trials.
This recommendation applies to asymptomatic women. It does not apply to women with known genetic mutations that increase their risk for ovarian cancer (for example, BRCA mutations).
The USPSTF recommends against screening for ovarian cancer in women (D recommendation).
重新确认 2004 年美国预防服务工作组（USPSTF）关于卵巢癌筛查的建议声明。
USPSTF 委托进行的 2008 年文献回顾没有发现有关卵巢癌筛查益处的新证据，但提供了一些关于筛查观察到的危害的新数据。到 2011 年的桥梁搜索重点是来自随机对照试验的证据。
本建议适用于无症状女性。它不适用于已知遗传突变增加卵巢癌风险的女性（例如 BRCA 突变）。
USPSTF 建议不对女性进行卵巢癌筛查（D 级建议）。
